![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bruker Corporation | NASDAQ:BRKR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 0.16% | 61.47 | 60.96 | 61.95 | 61.89 | 60.695 | 61.40 | 657,975 | 01:00:00 |
BILLERICA, Mass., Aug. 31, 2016 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences:
Wells Fargo 2016 Healthcare Conference
Wednesday, September 7, 2016, at 9:55 a.m. Eastern Time
Westin Waterfront Hotel, Boston, MA
Frank Laukien, President and Chief Executive Officer
Tony Mattacchione, Senior Vice President and Chief Financial Officer
Morgan Stanley Global Healthcare Conference
Monday, September 12, 2016, at 11:05 a.m. Eastern Time
Grand Hyatt Hotel, New York City, NY
Stacey Desrochers, Treasurer and Director of Investor Relations
A live audio webcast of both presentations will be available on the Investor section of the Company's Web site at http://ir.bruker.com. Replays of the presentations will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentations.
About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit: http://www.bruker.com.
Contact:
Stacey Desrochers
Treasurer and Director of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1115
Stacey.Desrochers@Bruker.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-investor-conferences-300320365.html
SOURCE Bruker Corporation
Copyright 2016 PR Newswire
1 Year Bruker Chart |
1 Month Bruker Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions